MHMatthias Hübenthal

Matthias Hübenthal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthias Hübenthal has a total of 395 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Psychoedukativer schematherapeutischer Ansatz bei Psoriasis und atopischer Dermatitis: Eine randomisierte kontrollierte Pilot‐Crossover‐Studie

    by Regina von Spreckelsen, Hila Emmert, Jan Hartmann, Matthias Hübenthal, Stephan Weidinger, Ulrich Mrowietz, Eva M. J. Peters, Sascha Gerdes

    Zusammenfassung: Hintergrund und Ziele: Atopische Dermatitis und Psoriasis sind chronisch‐entzündliche Hauterkrankungen, die häufig mit psychischem Stress einhergehen. Integrative Versorgungsmodelle fehlen weitestgehend. Diese randomisierte Pilotstudie hatte zum Ziel, zu der dermatologischen Behandlung eine begleitende schematherapeutisch ausgerichtete psychoedukative Kurzzeitintervention für dermatologische Patienten zu entwickeln und zu testen. Patienten und Methodik: Patienten aus einem ambulanten Entzündungszentrum mit einem PHQ‐2 (Patient Health Questionnaire‐2) Score ≥ 3 wurden randomisiert und einer Interventions‐ oder Kontrollgruppe zugewiesen. Die Interventionsgruppe erhielt drei standardisierte Sitzungen mit den Schwerpunkten maladaptive Schemata, Bewältigungsstrategien, Psychoedukation und emotionsfokussierte Techniken (zum Beispiel Stuhldialoge, Imagination). Ergebnisse: 19 Betroffene erhielten die Intervention, 13 gehörten zur Kontrollgruppe. Nach der Intervention wurden signifikante Verbesserungen der dermatologischen Lebensqualität (DLQI), des subjektiven Wohlbefindens (WHO‐5) und der depressiven Symptome (PHQ‐9, BDI‐II) beobachtet. Sie waren weitgehend unabhängig vom Schweregrad der Erkrankung (PASI, EASI). Qualitative Rückmeldungen hoben die Benutzerfreundlichkeit, das Erlernen spezifischer Techniken und eine vertrauensvolle therapeutische Beziehung hervor. Schlussfolgerungen: Eine kurze psychologische Intervention reduziert die psychische Belastung bei dermatologischen ambulanten Patienten signifikant. Weitere Studien sollten die langfristigen Auswirkungen und eine breitere Umsetzung untersuchen.

  • Open Access

    Psychoeducational schema therapy for psoriasis and atopic dermatitis: a randomized controlled pilot crossover trial

    by Regina von Spreckelsen, Hila Emmert, Jan Hartmann, Matthias Hübenthal, Stephan Weidinger, Ulrich Mrowietz, Eva M. J. Peters, Sascha Gerdes

    Summary: Background and objectives: Atopic dermatitis and psoriasis are chronic inflammatory skin diseases often linked to psychological stress. Integrative care models are lacking. This randomized pilot study aimed to develop and test a psychoeducational intervention for dermatology patients. Patients and methods: Patients with a PHQ‐2 score ≥ 3 at an outpatient inflammation center were randomized into an intervention or control group. The intervention group received three standardized educational sessions focusing on maladaptive schemas, coping strategies, psychoeducation, and emotion‐focused techniques (e.g. chair‐dialogues, imaginary rescripting). Results: 19 patients received the intervention; 13 were in the control group. Post‐intervention, significant improvements were observed in dermatological quality of life (DLQI), subjective well‐being (WHO‐5), and depressive symptoms (PHQ‐9, BDI‐II). Psychological benefits were largely independent of disease severity (PASI, EASI). Qualitative feedback highlighted usability, learning specific techniques, and a trusting therapeutic relationship. Conclusions: A brief psychoeducational intervention significantly reduced psychological stress in dermatology outpatients. Further studies are needed to evaluate long‐term effects and broader implementation.

  • Open Access

    Robust prediction of response to growth hormone therapy by five PBMC-based transcripts

    by Valerie van Kekem, Irene Victoria Bermúdez-Pérez, Alexandra E. Kulle, Maik Welzel, Nadine Hornig, Gerhard Binder, Matthias Hübenthal, Robert Häsler, Paul-Martin Holterhus

  • Open Access

    The Inflammatory Skin Disease map: an interactive computational resource focused on molecular mechanisms in psoriasis and atopic dermatitis

    by Marcio L Acencio, Oxana Lopata, Ahmed A Hemedan, Nick Dand, Stephan Weidinger, Lavinia Paternoster, Sara J Brown, Joseph Rastrick, Catherine H Smith, Matthias Hübenthal, et al.

    In this research letter, we introduce the Inflammatory Skin Diseases (ISD) map, a visual and computational representation of a molecular interaction network of molecular mechanisms of atopic dermatitis (AD) and psoriasis (PsO) (https://disease-maps.io/isd/). This knowledge repository can be used as a graphical review, to visualize complex omics data, or as a simulation testbed for research hypotheses. The purpose of the ISD map is to represent key molecular mechanisms of AD and PsO, facilitating information search and data interpretation, and supporting computational analyses.


  • Open Access

    Tralokinumab Treatment of Atopic Dermatitis Induces a Progressive Transcriptomic Response

    by Rashmi Tandon, Inken Harder, Dora Stölzl, Matthias Hübenthal, Nicole Sander, Jan Hartmann, Ina Suhrkamp, Melina Fonfara, Sascha Gerdes, Stephan Weidinger


  • Open Access

    Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study

    by Hila Emmert, Franziska Rademacher, Matthias Hübenthal, Regine Gläser, Hanne Norsgaard, Stephan Weidinger, Jürgen Harder


  • Open Access

    Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data

    by Matthias Hübenthal, Chengliang Dai, Sara J Brown, Luise Heinrich, Barbara Kind, Inken Harder, Jochen Schmitt, Thomas Werfel, Stephan Weidinger

    We used data from 1501 patients to build mathematical models for mapping between common measures of atopic dermatitis severity, including SCORing of Atopic Dermatitis (SCORAD), objective SCORAD (oSORAD) and the Eczema Area and Severity Index (EASI). These models can be used to facilitate progress in harmonizing patient data across studies, enabling important comparative analyses at scale.


  • Open Access

    Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism

    by Ruwen Böhm, Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Lena Ehmke, Jan Höcker, Werner Siegmund, Andre Franke, Ingolf Cascorbi

    Although great progress has been made in the fine‐tuning of diplotypes, there is still a need to further improve the predictability of individual phenotypes of pharmacogenetically relevant enzymes. The aim of this study was to analyze the additional contribution of sex and variants identified by exome chip analysis to the metabolic ratio of five probe drugs. A cocktail study applying dextromethorphan, losartan, omeprazole, midazolam, and caffeine was conducted on 200 healthy volunteers. CYP2D6, 2C9, 2C19, 3A4/5, and 1A2 genotypes were analyzed and correlated with metabolic ratios. In addition, an exome chip analysis was performed. These SNPs correlating with metabolic ratios were confirmed by individual genotyping. The contribution of various factors to metabolic ratios was assessed by multiple regression analysis. Genotypically predicted phenotypes defined by CPIC discriminated very well the log metabolic ratios with the exception of caffeine. There were minor sex differences in the activity of CYP2C9, 2C19, 1A2, and CYP3A4/5. For dextromethorphan (CYP2D6), IP6K2 (rs61740999) and TCF20 (rs5758651) affected metabolic ratios, but only IP6K2 remained significant after multiple regression analysis. For losartan (CYP2C9), FBXW12 (rs17080138), ZNF703 (rs79707182), and SLC17A4 (rs11754288) together with CYP diplotypes, and sex explained 50% of interindividual variability. For omeprazole (CYP2C19), no significant influence of CYP2C:TG haplotypes was observed, but CYP2C19 rs12777823 improved the predictability. The comprehensive genetic analysis and inclusion of sex in a multiple regression model significantly improved the explanation of variability of metabolic ratios, resulting in further improvement of algorithms for the prediction of individual phenotypes of drug‐metabolizing enzymes.


  • Open Access

    A novel unconventional T cell population enriched in Crohn’s disease

    by Elisa Rosati, Gabriela Rios Martini, Mikhail V Pogorelyy, Anastasia A Minervina, Frauke Degenhardt, Mareike Wendorff, Soner Sari, Gabriele Mayr, Antonella Fazio, Christel Marie Dowds, et al.

    Objective: One of the current hypotheses to explain the proinflammatory immune response in IBD is a dysregulated T cell reaction to yet unknown intestinal antigens. As such, it may be possible to identify disease-associated T cell clonotypes by analysing the peripheral and intestinal T-cell receptor (TCR) repertoire of patients with IBD and controls. Design: We performed bulk TCR repertoire profiling of both the TCR alpha and beta chains using high-throughput sequencing in peripheral blood samples of a total of 244 patients with IBD and healthy controls as well as from matched blood and intestinal tissue of 59 patients with IBD and disease controls. We further characterised specific T cell clonotypes via single-cell RNAseq. Results: We identified a group of clonotypes, characterised by semi-invariant TCR alpha chains, to be significantly enriched in the blood of patients with Crohn’s disease (CD) and particularly expanded in the CD8 + T cell population. Single-cell RNAseq data showed an innate-like phenotype of these cells, with a comparable gene expression to unconventional T cells such as mucosal associated invariant T and natural killer T (NKT) cells, but with distinct TCRs. Conclusions: We identified and characterised a subpopulation of unconventional Crohn-associated invariant T (CAIT) cells. Multiple evidence suggests these cells to be part of the NKT type II population. The potential implications of this population for CD or a subset thereof remain to be elucidated, and the immunophenotype and antigen reactivity of CAIT cells need further investigations in future studies.


  • Top Cited Papers
    Open Access

    Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

    by Chris Eijsbouts, Tenghao Zheng, Nicholas A. Kennedy, Ferdinando Bonfiglio, Carl A. Anderson, Loukas Moutsianas, Joanne Holliday, Jingchunzi Shi, Suyash Shringarpure, Alexandru-Ioan Voda, et al.

    Irritable bowel syndrome (IBS) results from disordered brain–gut interactions. Identifying susceptibility genes could highlight the underlying pathophysiological mechanisms. We designed a digestive health questionnaire for UK Biobank and combined identified cases with IBS with independent cohorts. We conducted a genome-wide association study with 53,400 cases and 433,201 controls and replicated significant associations in a 23andMe panel (205,252 cases and 1,384,055 controls). Our study identified and confirmed six genetic susceptibility loci for IBS. Implicated genes included NCAM1, CADM2, PHF2/FAM120A, DOCK9, CKAP2/TPTE2P3 and BAG6. The first four are associated with mood and anxiety disorders, expressed in the nervous system, or both. Mirroring this, we also found strong genome-wide correlation between the risk of IBS and anxiety, neuroticism and depression (rg > 0.5). Additional analyses suggested this arises due to shared pathogenic pathways rather than, for example, anxiety causing abdominal symptoms. Implicated mechanisms require further exploration to help understand the altered brain–gut interactions underlying IBS.